Mayne Pharma Commercial LLC
NDC labeler codes: 51862, 68308
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- DoxycyclineDoxy 100, Doryx Mpc, Acticlate Cap · 2 products
- Benzoyl peroxideEpsolay · 1 product
- ItraconazoleTolsura, Sporanox · 1 product
- Methamphetamine hydrochloride1 product
- Tamoxifen citrateSoltamox · 1 product
- DapsoneAczone · 1 product
- Chlorzoxazone1 product
- AdapaleneDifferin · 1 product
- Tavaborole1 product
- Benzoyl peroxide and tretinoinTwyneo · 1 product
FDA applications for these products
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| April 22, 2022 | NDA214510 | Benzoyl peroxide EPSOLAY | Mayne Pharma |
| February 10, 2022 | ANDA214722 | Dapsone DAPSONE | Torrent |
| July 26, 2021 | NDA214902 | Benzoyl peroxide and tretinoin TWYNEO | Mayne Pharma |
| October 13, 2020 | ANDA211297 | Tavaborole TAVABOROLE | Encube |
| July 21, 2020 | ANDA211849 | Chlorzoxazone CHLORZOXAZONE | DR Reddys Labs SA |
| December 11, 2018 | NDA208901 | Itraconazole TOLSURA | Mayne Pharma |
| April 21, 2010 | ANDA091189 | Methamphetamine hydrochloride METHAMPHETAMINE HYDROCHLORIDE | DR Reddys Labs SA |
| June 19, 2007 | NDA021753 | Adapalene DIFFERIN | Galderma Labs LP |
| May 6, 2005 | NDA050795 | Doxycycline DORYX, DORYX MPC | Mayne Pharma |
| February 20, 2003 | ANDA075797 | Tamoxifen citrate TAMOXIFEN CITRATE | DR Reddys Labs SA |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2022
-
June 9, 2022 · Class II · Terminated · D-1152-2022 · Clonidine
Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.
Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only, Manufactured for: Mayne Pharma Greenville, NC 27834
2018
-
March 21, 2018 · Class III · Terminated · D-0616-2018 · Tazarotene
Superpotent Drug: High out of specification results for tazarotene assay at the 9-month stability time point.
Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834; NDC 51862-295-10.
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026